Literature DB >> 21231989

Effects of a topical microemulsion in house dust mite allergic rhinitis.

Morgan Andersson1, Lennart Greiff, Per Wollmer.   

Abstract

We have previously demonstrated that a topical microemulsion can attenuate symptoms and signs of seasonal allergic rhinitis. This likely reflects that the microemulsion interferes with the interaction between the allergen and the mucosa. Whether or not the finding translates to conditions caused by other inhaled agents such as house dust mite allergen is unknown. Patients with perennial allergic rhinitis caused by house dust mite were subjected to topical microemulsion treatment in a randomized, double-blinded and crossover design with isotonic saline as control. Morning symptoms were monitored, change from baseline was assessed and the treatments were compared. On the first days of the isotonic saline and microemulsion runs, before any treatment was given, total nasal symptoms were scored to 2.8 and 3.1 (range 0-9), respectively. Nasal symptoms were reduced by intervention with the microemulsion: the change from baseline was consistent for the microemulsion and the difference between the microemulsion and isotonic saline reached statistical significance in favour of the former. We conclude that intervention with a microemulsion may reduce symptoms of house dust mite allergic rhinitis at natural allergen exposure. Our findings suggest the possibility that topical microemulsions can be a useful option to reduce nasal mucosal exposure to allergen in perennial allergic rhinitis..
© 2010 The Authors. Basic & Clinical Pharmacology & Toxicology © 2010 Nordic Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21231989     DOI: 10.1111/j.1742-7843.2010.00640.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  4 in total

1.  Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies.

Authors:  Alan D Rogol; Natalia Tkachenko; Philipp Badorrek; Jens M Hohlfeld; Nathan Bryson
Journal:  Can Urol Assoc J       Date:  2018-03-19       Impact factor: 1.862

2.  Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study.

Authors:  Barbara De Servi; Francesco Ranzini; Núria Piqué
Journal:  Allergy Asthma Clin Immunol       Date:  2017-08-10       Impact factor: 3.406

3.  Dehydration affects drug transport over nasal mucosa.

Authors:  Abdullah Ali; Marie Wahlgren; Birgitta Rembratt-Svensson; Ameena Daftani; Peter Falkman; Per Wollmer; Johan Engblom
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

4.  A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study).

Authors:  Pedro Ojeda; Núria Piqué; Alicia Alonso; Julio Delgado; Francisco Feo; Juan Manuel Igea; Ana Navarro; José María Olaguibel; Javier Subiza; Carles Nieto; Morgan Andersson
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-27       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.